Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
AstraZeneca
Boehringer Ingelheim
US Army
McKesson
Chubb
Chinese Patent Office
Julphar
Dow

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019836

« Back to Dashboard

NDA 019836 describes SUPPRELIN, which is a drug marketed by Shire and Endo Pharm and is included in two NDAs. There is one patent protecting this drug. Additional details are available on the SUPPRELIN profile page.

The generic ingredient in SUPPRELIN is histrelin acetate. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the histrelin acetate profile page.
Summary for 019836
Tradename:SUPPRELIN
Applicant:Shire
Ingredient:histrelin acetate
Patents:0
Therapeutic Class:Hormonal Agents, Suppressant (Pituitary)
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 0.2MG BASE/ML
Approval Date:Dec 24, 1991TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 0.5MG BASE/ML
Approval Date:Dec 24, 1991TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 1MG BASE/ML
Approval Date:Dec 24, 1991TE:RLD:No

Expired US Patents for NDA 019836

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Shire SUPPRELIN histrelin acetate INJECTABLE;INJECTION 019836-003 Dec 24, 1991 ➤ Sign Up ➤ Sign Up
Shire SUPPRELIN histrelin acetate INJECTABLE;INJECTION 019836-001 Dec 24, 1991 ➤ Sign Up ➤ Sign Up
Shire SUPPRELIN histrelin acetate INJECTABLE;INJECTION 019836-002 Dec 24, 1991 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Deloitte
Express Scripts
AstraZeneca
Fuji
Healthtrust
Farmers Insurance
Federal Trade Commission
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.